71 results
8-K
EX-10.1
NNMX
NANOMIX Corp
25 Jan 23
Nanomix Appoints Finance Veteran Chris Hetterly as Chief Financial Officer
4:43pm
8-K
EX-10.1
NNMX
NANOMIX Corp
10 Nov 22
Unregistered Sales of Equity Securities
8:35am
8-K
EX-10.1
NNMX
NANOMIX Corp
29 Jul 22
Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger as Chief Executive Officer and Member of the Board of Directors
3:57pm
8-K
EX-10.1
NNMX
NANOMIX Corp
10 May 22
Nanomix Appoints Vidur Sahney as Chief Operating Officer
4:06pm
10-K
2021 FY
EX-10.24
NNMX
NANOMIX Corp
Annual report
12 Apr 22
5:15pm
8-K
EX-10.1
h6rwb
24 Mar 22
Entry into a Material Definitive Agreement
9:13am
8-K
EX-10.2
eudbepze9vzbmkmg
24 Mar 22
Entry into a Material Definitive Agreement
9:13am
8-K
EX-10.2
1xv 062vwrx50ry9
1 Mar 22
Entry into a Material Definitive Agreement
8:58am
8-K
EX-10.1
r5u51soch6wktzcdx
1 Mar 22
Entry into a Material Definitive Agreement
8:58am
8-K
EX-10.4
9gsin80k5 uw7gqxy
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-10.1
gq3urd0k9wj7jb
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-10.3
hs8lzleuic7ppan
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-10.5
uwfu1nu
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-10.2
pca g3cpq
29 Jun 21
Boston Therapeutics Announces $8.4 Million Convertible Placement
9:06am
8-K
EX-10.1
0909uta
12 May 21
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.1
6yvwj
2 Feb 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.2
4b9aphtxe9h ujh9
2 Feb 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
s3usq7xde6pv 0n
2 Jul 18
Entry into a Material Definitive Agreement
3:50pm